Janney Montgomery Scott Upgrades Sarepta Therapeutic (SRPT) to Buy
Tweet
Share
E-mail
Get Alerts SRPT Hot Sheet
Price: $20.11 -2.71%
Rating Summary:
19 Buy, 18 Hold, 6 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 19 | Down: 9 | New: 26
Rating Summary:
19 Buy, 18 Hold, 6 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 19 | Down: 9 | New: 26
Join SI Premium – FREE
Janney Montgomery Scott upgraded Sarepta Therapeutic (NASDAQ: SRPT) from Neutral to Buy with a price target of $65.00.
For an analyst ratings summary and ratings history on Sarepta Therapeutic click here. For more ratings news on Sarepta Therapeutic click here.
Shares of Sarepta Therapeutic closed at $28.15 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Deutsche Bank Upgrades Wickes Group plc (WIX:LN) to Hold
- Erste Group Upgrades Toyota Motor (TM) to Buy, 'more profitable than its competitors'
- BofA Securities Upgrades Equinor ASA (ADR) (EQNR) to Buy
Create E-mail Alert Related Categories
UpgradesRelated Entities
Janney Montgomery ScottSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
